Bismuth(III) subsalicylate
ALDRICH/480789 - 99.9% trace metals basis
Synonym: Bismuth oxysalicylate; Bismuth subsalicylate; Bismuth(III) salicylate basic
CAS Number: 14882-18-9
Empirical Formula (Hill Notation): C7H5BiO4
Molecular Weight: 362.09
EC Number: 238-953-1
MDL Number: MFCD00085368
Linear Formula: HOC6H4COOBiO
Product Type: Chemical
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: 480789-100G
This image depicts SKU: 480789-100G
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: 480789-500G
This image depicts SKU: 480789-500G
| assay | 99.9% trace metals basis |
| InChI | 1S/C7H6O3.Bi.H2O/c8-6-4-2 |
| InChI key | ZREIPSZUJIFJNP-UHFFFAOYSA |
| mp | >350 °C (lit.) |
| Quality Level | 100  |
| reaction suitability | core: bismuth |
| reagent type: catalyst | |
| SMILES string | O[Bi]1OC(=O)c2ccccc2O1 |
| Application: | • Use of ferric chloride to identify salicylate-containing poisons.: This study explores the use of ferric chloride to detect salicylate compounds, including Bismuth subsalicylate, highlighting its significance in toxicological screenings and emergency treatments. (Hoffman RJ et al., 2002  ).• Effect of pepper and bismuth subsalicylate on gastric pain and surface hydrophobicity in the rat.: Investigates the effects of Bismuth subsalicylate on gastric pain and stomach lining properties, providing insights into its gastroprotective mechanisms. (Lichtenberger LM et al., 1998 ).• The coccoid forms of Helicobacter pylori. Criteria for their viability.: Examines the effectiveness of Bismuth subsalicylate in targeting different morphological forms of Helicobacter pylori, contributing to its role in eradication therapies. (Bode G et al., 1993 ).• Bismuth therapy in gastrointestinal diseases.: A comprehensive review of the therapeutic applications of Bismuth subsalicylate in treating various gastrointestinal disorders, underscoring its pharmacological benefits and safety profile. (Gorbach SL, 1990 ). |
| General description: | Bismuth(III) subsalicylate (BSS) is mainly used in bismuth-based medicines for treating gastrointestinal disorders and diarrhea. |
| Packaging: | 100, 500 g in poly bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | 99.9% trace metals basis |
| mp | >350 °C (lit.) |
| UNSPSC | 12161600 |